29-39 Brunswick Square
6 articles with Spirogen Ltd.
AstraZeneca PLC's MedImmune Takes Over Spirogen Ltd. for Up to $400 Million to Bolster Oncolology Portfolio
Ablynx and Spirogen Ltd. Enter Into a Research Collaboration to Evaluate the Potential of Novel Toxin-Nanobody Drug Conjugates in Cancer
PolyTherics Announces a Research Collaboration With Spirogen Ltd. to Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
PolyTherics and Spirogen Ltd. Announce a Research Collaboration to Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
Spirogen Ltd. Announces a Research Collaboration and License Agreement with Spirogen Ltd. for the Discovery and Development of Antibody Drug Conjugates